Abstract
In this issue of Blood, Antoniani et al identify an innovative genome editing approach to induce fetal hemoglobin (HbF), which may eventually lead to therapeutic strategies for ameliorating or curing sickle-cell disease (SCD) and b-thalassemia.
Cite
CITATION STYLE
APA
Montbleau, K. E., & Sankaran, V. G. (2018, April 26). A chance to cut (the genome) is a chance to cure. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2018-03-839787
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free